Kindlymd announces pricing of $6.8 million initial public offering

Salt lake city, ut / accesswire / may 31, 2024 / kindlymd, inc. (nasdaq:kdly)(nasdaq:kdlyw) ("kindlymd" or the "company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced the pricing of its initial public offering of 1,240,910 units (each, a "unit," collectively, the "units") at a price of $5.50 per unit for a total of approximately $6.8 million of gross proceeds to the company. each unit is comprised of one share of the company's common stock with $0.001 par value per share ("common stock"), one tradeable warrant (each, a "tradeable warrant," collectively, the "tradeable warrants") to purchase one share of common stock at an exercise price of $6.33 per share, and one non-tradeable warrant (each, a "non-tradeable warrant," collectively, the "non-tradeable warrants") to purchase one-half of one share of common stock at an exercise price of $6.33 per share.
NAKA Ratings Summary
NAKA Quant Ranking